A prospective trial to evaluate the safety and efficacy of ATI-1501 in children with Clostridium difficile infection

Trial Profile

A prospective trial to evaluate the safety and efficacy of ATI-1501 in children with Clostridium difficile infection

Planning
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Metronidazole (Primary)
  • Indications Clostridium infections
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Apr 2016 New trial record
    • 12 Apr 2016 According to an Appili Therapeutics media release, the company plans start clinical trials of ATI-1501 for Clostridium difficile infection in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top